Form 8-K - Current report:
SEC Accession No. 0001641172-25-024007
Filing Date
2025-08-14
Accepted
2025-08-14 16:07:09
Documents
14
Period of Report
2025-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 39214
2 EX-99.1 ex99-1.htm EX-99.1 108504
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4861
  Complete submission text file 0001641172-25-024007.txt   333678

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE celc-20250814.xsd EX-101.SCH 3014
5 XBRL LABEL FILE celc-20250814_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE celc-20250814_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3687
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Filer) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38207 | Film No.: 251218891
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)